Sofosbuvir/velpatasvir/voxilaprevir Interactions
Showing entire list of all interactions, including brand names and combination drugs.
Go back to interactions summary
Medications known to interact with sofosbuvir/velpatasvir/voxilaprevir
Z
- Zafemy (ethinyl estradiol / norelgestromin)
- Zantac (ranitidine)
- Zantac 360 (famotidine)
- Zarah (drospirenone / ethinyl estradiol)
- zavegepant
- Zavzpret (zavegepant)
- Zcort (dexamethasone)
- Zee-Seltzer Antacid and Pain Reliever (aspirin/citric acid/sodium bicarbonate)
- Zegerid (omeprazole / sodium bicarbonate)
- Zegerid (Original Formulation) (omeprazole)
- Zegerid OTC (omeprazole / sodium bicarbonate)
- Zejula (niraparib)
- Zelboraf (vemurafenib)
- Zema Pak (dexamethasone)
- Zenchent (ethinyl estradiol / norethindrone)
- Zenchent Fe (ethinyl estradiol / norethindrone)
- Zeosa (ethinyl estradiol / norethindrone)
- Zepatier (elbasvir / grazoprevir)
- Zepbound (tirzepatide)
- Zituvimet (metformin / sitagliptin)
- Zituvio (sitagliptin)
- Zocor (simvastatin)
- ZoDex (dexamethasone)
- Zomacton (somatropin)
- Zonacort (dexamethasone)
- Zorbtive (somatropin)
- Zortress (everolimus)
- Zovia 1 / 35 (ethinyl estradiol / ethynodiol)
- Zovia 1 / 35E (ethinyl estradiol / ethynodiol)
- Zovia 1 / 50E (ethinyl estradiol / ethynodiol)
- Zumandimine (drospirenone / ethinyl estradiol)
- Zydelig (idelalisib)
- Zypitamag (pitavastatin)
- Zytiga (abiraterone)
More about sofosbuvir / velpatasvir / voxilaprevir
- sofosbuvir/velpatasvir/voxilaprevir consumer information
- Check interactions
- Compare alternatives
- Reviews (2)
- Side effects
- Dosage information
- During pregnancy
- Drug class: antiviral combinations
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.